Instil Bio, Inc. (TIL)

Instil Bio Statistics

Total Valuation

Instil Bio has a market cap or net worth of $111.07 million. The enterprise value is $84.64 million.

Market Cap	111.07M
Enterprise Value	84.64M

Important Dates

The last earnings date was Tuesday, March 4, 2025, before market open.

Earnings Date	Mar 4, 2025
Ex-Dividend Date	n/a

Share Statistics

Instil Bio has 6.53 million shares outstanding. The number of shares has increased by 0.10% in one year.

Current Share Class	6.53M
Shares Outstanding	6.53M
Shares Change (YoY)	+0.10%
Shares Change (QoQ)	+0.32%
Owned by Insiders (%)	3.14%
Owned by Institutions (%)	26.89%
Float	2.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.66
P/TBV Ratio	0.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.76, with a Debt / Equity ratio of 0.51.

Current Ratio	15.76
Quick Ratio	14.35
Debt / Equity	0.51
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.67

Financial Efficiency

Return on equity (ROE) is -37.51% and return on invested capital (ROIC) is -13.19%.

Return on Equity (ROE)	-37.51%
Return on Assets (ROA)	-12.72%
Return on Invested Capital (ROIC)	-13.19%
Return on Capital Employed (ROCE)	-23.45%
Revenue Per Employee	n/a
Profits Per Employee	-$5.30M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +57.59% in the last 52 weeks. The beta is 1.74, so Instil Bio's price volatility has been higher than the market average.

Beta (5Y)	1.74
52-Week Price Change	+57.59%
50-Day Moving Average	20.62
200-Day Moving Average	24.15
Relative Strength Index (RSI)	41.90
Average Volume (20 Days)	73,350

Short Selling Information

The latest short interest is 547,298, so 8.39% of the outstanding shares have been sold short.

Short Interest	547,298
Short Previous Month	527,771
Short % of Shares Out	8.39%
Short % of Float	20.50%
Short Ratio (days to cover)	6.03

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-59.96M
Pretax Income	-123.32M
Net Income	-74.14M
EBITDA	-56.35M
EBIT	-59.96M
Earnings Per Share (EPS)	-$11.39

Balance Sheet

The company has $113.32 million in cash and $86.89 million in debt, giving a net cash position of $26.43 million or $4.05 per share.

Cash & Cash Equivalents	113.32M
Total Debt	86.89M
Net Cash	26.43M
Net Cash Per Share	$4.05
Equity (Book Value)	169.44M
Book Value Per Share	25.96
Working Capital	116.57M

Cash Flow

Operating Cash Flow	-55.70M
Capital Expenditures	n/a
Free Cash Flow	-55.70M
FCF Per Share	-$8.53

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Instil Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.10%
Shareholder Yield	-0.10%
Earnings Yield	-66.75%
FCF Yield	-50.14%

Analyst Forecast

The average price target for Instil Bio is $114.00, which is 569.80% higher than the current price. The consensus rating is "Buy".

Price Target	$114.00
Price Target Difference	569.80%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on December 8, 2023. It was a reverse split with a ratio of 0.05:1.

Last Split Date	Dec 8, 2023
Split Type	Reverse
Split Ratio	0.05:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2